mitochondrial-derived 16-residue peptide

MOTS-c updates

Name: MOTS-c updates
Creator: Global Peptide Index
License: https://globalpeptideindex.com/methodology

Answer

4 changes for MOTS-c in the last 12 months. Latest: 2026-07-01.

Date	Type	What changed	Source
2026-07-01	Trial	New trial registered: Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplan	Trial register ClinicalTrials.gov
2026-04-16	Action	Ohio Board of Pharmacy: board	Regulator Ohio Board of Pharmacy
2026-04-16	Federal Register	Federal Register notice: Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated	Regulator Federal Register
2026-04-01	Trial	New trial registered: MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity	Trial register ClinicalTrials.gov
2023-11-08	Trial	New trial registered: Cohort Of DEafness-gene Screening	Trial register ClinicalTrials.gov
2019-07-22	Trial	New trial registered: Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD	Trial register ClinicalTrials.gov
2019-02-11	Trial	New trial registered: The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination	Trial register ClinicalTrials.gov

From ClinicalTrials.gov, EU CTIS, FDA labels, recalls, shortages and warning letters, the Federal Register, and regulators' published actions. Not medical advice.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.